Thu, Aug 21, 2014, 8:23 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

GW Pharmaceuticals plc Message Board

  • flshtogo flshtogo Oct 14, 2013 2:00 PM Flag

    PUGE: U.S. #$%$ market will quadruple next five years.

    GWP decade ahead of competitors THC and cannaboid delivery method. $62 target is conservative.

    There is no US approved drug to treat PTSD. Cannoboid may be the cure.
    OTC: PUGE Cannabis BioTech is investigating alternatives such as topical applications and infusing active ingredients into foods and beverages, which will open up the benefits to a significantly larger segment of the population. The company is also exploring sophisticated transmucosal delivery systems (administered through the mucous membranes).

    According to a recent Pew Research report, for the first time in more than 40 years a majority of Americans favor legalization of marijuana use. The manner in which it is consumed is producing a fast-growing industry in alternative delivery methods. The Wall Street Journal reported the $1.7 billion U.S. #$%$ market will quadruple in size during the next five years.

    PROFIT: Projected cannabis sales are $3 billion in 2014 and $6 billion in 2016. In US 20 states plus the District of Columbia have legalized cannabis for medical reasons and the list of states will continue to grow.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
89.05-1.95(-2.14%)Aug 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
EMCOR Group Inc.
NYSEThu, Aug 21, 2014 4:01 PM EDT
NXP Semiconductors NV
NasdaqGSThu, Aug 21, 2014 4:00 PM EDT
GameStop Corp.
NYSEThu, Aug 21, 2014 4:01 PM EDT